5 Biotech Penny Stocks to Buy Now

2. Second Sight Medical Products, Inc. (NASDAQ:EYES)

Number of Hedge Fund Holders: 6  

Second Sight Medical Products, Inc. (NASDAQ:EYES) makes and sells microbiome metabolic therapies. The stock has surged manifold since July after the firm was granted a patent by European authorities regarding field focusing and mapping in an electrode array.

Second Sight Medical Products, Inc. (NASDAQ:EYES) recently announced that it had won a grant from the National Institutes of Health for the trial of Orion, a device developed by the firm to provide artificial vision for blind people.

At the end of the third quarter of 2021, 6 hedge funds in the database of Insider Monkey held stakes worth $20 million in Second Sight Medical Products, Inc. (NASDAQ:EYES), the same as in the preceding quarter worth $4 million.